ARCHIVES

NCI Payline To Jump To 25th Percentile For A Portion Of Grants, Director Says

This article is from The Cancer Letter archive.

Vol. 35 No. 16 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

New Evidence Shows Polyp Removal Lowers Death Rate at 23-Year Follow-up

February 24, 2012

Amgen Says ESA Use Dropped By Half In Fourth Quarter.

January 25, 2008

ACD Asks Senate To Raise Budget Of CDC Cancer Programs

July 30, 1993

In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts”

March 26, 1976

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

August 14, 1992